Powered by: Motilal Oswal
2025-02-07 09:50:11 am | Source: Geojit Financial Services Ltd
Market Watch :RBI decision awaited: Rate cut or liquidity infusion ? - Geojit Financial Services Ltd
Market Watch :RBI decision awaited: Rate cut or liquidity infusion ? - Geojit Financial Services Ltd

 

Asia

Asian stocks declined on Friday following subdued movements on Wall Street, as traders anticipated U.S. jobs data that will provide insights into future interest rate decisions. Gift Nifty suggests a flat opening for Indian markets.

US & Europe

The S&P 500 and Nasdaq finished higher, whereas the Dow ended lower following a volatile trading session on Thursday. Investors analyzed earnings reports and anticipated Amazon's results postmarket, along with a crucial jobs report on Friday. Meanwhile, European markets reached a record high on Thursday, driven by numerous earnings announcements and a 0.25% rate cut by the Bank of England.

Commodities

Oil prices declined on Thursday after U.S. President Donald Trump reiterated his commitment to increasing U.S. oil production, unsettling traders a day after the country reported a significantly larger-than-expected rise in crude inventories. Gold prices dropped 1% on Thursday as the U.S. dollar strengthened ahead of a crucial jobs report, prompting investors to take profits following five consecutive sessions of record highs driven by escalating trade tensions between the U.S. and China.

* Events today: RBI MPC meeting outcome, US Fed balance sheet/ Non Farm Payrolls/ Baker Hughes oil rig count, Japan/ China FX Reserves.

* Ex-date: ONGC, Power Grid Corp, Nestle, GAIL, Chola Investment and Finance Corporation, Tube Investments (Dividend), Ksolves India (Split)

* Earnings today: Wockhardt, Va Tech Wabag, Zaggle Prepaid Ocean Services, VST Industries, Venkys, Sun TV Network, NHPC, Oil India.

* HG Infra was declared as L-1 bidder by Rail Land Development Authority (RLDA) to develop the railway station in a joint bid with DEC Infrastructure.

* Auropharma approved a plan to acquire 80 percent of Tergene Biotech Ltd, a subsidiary, making it a direct subsidiary of Aurobindo Pharma.

Nifty Outlook

The dip to 23550 region that took two days to unfold provides a window for an upswing to either 23680 or 23800. As maintained yesterday, the extended targets of 24020-24226 awaits further confirmation. Meanwhile, inability to float above 23680 would point towards further weakness or consolidation with 23476 or 23300 stepping in to avoid a collapse.

 

For More Geojit Financial Services Ltd Disclaimer https://www.geojit.com/disclaimer
SEBI Registration Number: INH200000345

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here